RT @lifebiomedguru: sAPPα levels are increased and BDNF levels decreased in the plasma of patients w/severe autism as compared to controls.…

sAPPα levels are increased and BDNF levels decreased in the plasma of patients w/severe autism as compared to controls. We show that Aβ1-40, Aβ1-42, and sAPPβ levels are significantly decreased in the plasma of patients with severe autism. #aluminum http

Increased Secreted Amyloid Precursor (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Biomarker http://awe.sm/5NcQt